Government’s investment will pay for about 200 million tests to replenish the country’s stockpile.

No significant reduction seen in percent of patients with urgent care or emergency department visits or hospitalization.

Findings reported for patients seeking treatment for opioid use disorder from 2016 to 2020.

A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.

However, amoxicillin-clavulanate tied to higher risk for adverse events, particularly in younger children.

Bacterial pneumonia treatment now available; FDA deny anaphylaxis treatment; flu vaccine efficacy results; flexible dosing for Talicia; change in the therapeutic equivalence for organ rejection drug generic. 

Travere Therapeutics will submit a supplemental New Drug Application for full approval of sparsentan in the first half of 2024.

Pegozafermin is an investigational glycoPEGylated analog of FGF21.

MWTX-003 is an investigational anti-TMPRSS6 designed to induce endogenous expression of hepcidin resulting in suppression of serum iron levels.

NexoBrid (anacaulase-bcdb) is now available for eschar removal in adults with deep partial thickness and/or full thickness thermal burns.